EClinicalMedicine · 2022 · 30 citations · 27 references
MedicinePharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyPharmacovigilanceWeight LossWeight ManagementClinical Weight ManagementLong-term MaintenanceLong-term Weight MaintenanceOpen-label TrialsPharmacotherapy For Weight LossPost Hoc AnalysisPrimary Outcome AnalysisWeight Loss Efficacy
Background: Extended-release (ER) naltrexone/bupropion (NB) was associated with greater weight loss than placebo in four randomized, 56-week trials. The association of NB with longer-term maintenance of weight loss remains unknown. Methods: analysis of four phase III, randomized, double-blind, placebo-controlled, 56-week studies (COR-I, COR-II, COR-BMOD, and COR-DM), the placebo-controlled cardiovascular outcomes trial LIGHT (208 weeks), and the randomized, open-label trial IGNITE (78 weeks). Included subjects were treated with NB 32 mg/360 mg or placebo, with baseline, week 16, and final time point data. The primary outcome was Kaplan-Meier-estimated weight loss maintenance in each study for up to 204 weeks. Findings: Our analysis included data from 10,198 particpants (NB=5412; placebo=4786). Proportions of patients with ≥5% or ≥10% weight loss maintenance were numerically higher for NB vs. placebo in all studies and time points. Differences were statistically significant for ≥5% weight loss maintenance in COR-BMOD and COR-I/-II at weeks 52 and 56 and the LIGHT study at weeks 52, 104, and 208. For ≥10% weight loss maintenance, differences were statistically significant in COR-I/COR-II at weeks 52 and 56. Interpretation: These data suggest that NB could be used as part of long-term, comprehensive weight loss and weight loss maintenance strategies. Funding: Orexigen Therapeutics, Inc. and Bausch Health Canada.
27
Nicholas R. Fuller, Stephen Colagiuri, Deborah Schofield et al. · International Journal of Obesity · 2012 · 2.1K citations · Full text
Pharmacy, Health Services Administration, Pharmacoeconomics +17
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Jarl Torgerson, Jonathan Hauptman, Mark Boldrin et al. · Diabetes Care · 2004 · 1.9K citations · Full text
Obesity in adults: a clinical practice guideline
Sean Wharton, David C.W. Lau, Michael Vallis et al. · Canadian Medical Association Journal · 2020 · 1.4K citations · Full text